Connect with us

Lifestyle

Weight-Loss Drug Access Drops as States End Medicaid Coverage

Published

on

Weight-Loss Drug Access Drops as States End Medicaid Coverage
Share This On:

A decision made by a health insurance program can quickly change whether people receive medicine.

New research shows just how dramatic that change can be for Americans using prescription drugs to manage their weight.

In four US states, Medicaid prescriptions for approved weight loss medicines plunged after coverage ended at the start of 2026. The researchers say the results raise concerns about interruptions to ongoing treatment.

Medicaid provides health coverage for many Americans with low incomes. Unlike most other prescription medicines, drugs used for weight loss do not have to be covered by state Medicaid programs.

The medicines examined belong to a group called GLP-1 drugs. They help people feel less hungry by copying the action of a hormone in the body, and some versions are also used to treat diabetes.

ALSO READ:  Benefits Of Groundnuts

California, New Hampshire, Pennsylvania and South Carolina stopped covering GLP-1 medicines prescribed for weight loss on January 1. Researchers at the University of Pittsburgh wanted to understand what happened to prescriptions immediately afterward.

They studied Medicaid records from across the country, dating back to 2022. The research was published in JAMA on November 16, 2026.

In the four states that cut coverage, prescriptions fell from 2,914 per 100,000 Medicaid members in the last three months of 2025 to just 421 in the first three months of 2026. Ten states that kept coverage experienced a much smaller decline.

ALSO READ:  Doctors Explain Why Your Liver Does Not Need a Detox Cleanse

After accounting for that comparison, the researchers estimated a drop of about 84% associated with the coverage cuts. Pennsylvania saw the biggest decrease, followed by New Hampshire, California and South Carolina.

The team also estimated that roughly 175,500 to 526,600 fewer people may have filled these prescriptions in the four states. That estimate is uncertain because one person can fill several prescriptions and some people may have paid for their medicine themselves.

Could patients simply have switched to diabetes versions of the drugs? The researchers found no meaningful overall rise in Medicaid prescriptions for those alternatives, although they could not track each person’s choices.

ALSO READ:  Health Benefits of Coconut Milk and What to Know Before Consuming It

Weight loss medicines often need to be taken over time to maintain their benefits. A sudden break may make weight management harder, but this study did not measure changes in body weight or health after coverage stopped.

The results are persuasive because the decline happened immediately and was much larger than in states that kept coverage. Still, this was a study of prescription patterns rather than a controlled experiment, so other policy changes may have played a part.

The broader message is that access to treatment depends not only on whether a medicine works, but also on whether people can afford to keep taking it.

Share This On:
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending